Streamline Health Solutions Third Quarter 2024 Earnings: Misses Expectations
Streamline Health Solutions (NASDAQ:STRM) Third Quarter 2024 Results
Key Financial Results
Revenue: US$6.13m (down 1.4% from 3Q 2023).
Net loss: US$11.9m (loss widened by 280% from 3Q 2023).
US$0.21 loss per share (further deteriorated from US$0.066 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Streamline Health Solutions Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 3.6%. Earnings per share (EPS) also missed analyst estimates.
Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare Services industry in the US.
Performance of the American Healthcare Services industry.
The company's shares are up 28% from a week ago.
Risk Analysis
It's necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Streamline Health Solutions (at least 2 which shouldn't be ignored), and understanding these should be part of your investment process.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
